Role of telepharmacy in pharmacist counselling to coronavirus disease 2019 patients and medication dispensing errors
Role of telepharmacy in pharmacist counselling to coronavirus disease 2019 patients and medication dispensing errors
复制标题
DOI：
10.1177/1357633x20964347
复制
发表时间：
2020-10-15
影响因子：
4.7
通讯作者：
Al Mazrouei, Nadia
中科院分区：
文献类型：
--
作者：
Ibrahim, Osama M.;Ibrahim, Rana M.;Al Mazrouei, Nadia
在2019年冠状病毒病(新冠肺炎)暴发期间，远程药剂师干预已经获得了更多的关注，因为它们降低了传播风险，并可能增加脆弱人群，如新冠肺炎患者，获得药物护理的机会。这项研究旨在检验有无远程药房服务的社区药店与有无远程药房服务的社区药店中与新冠肺炎和药物分配错误相关的药剂师干预的比率和类型的差异。方法采用比例随机抽样的方法，在阿拉伯联合酋长国所有7个州的52家社区药店(26家有远程药房，26家没有远程药房)进行了为期4个月(从2020年3月至2020年7月)的前瞻性、伪装、观察性研究。结果远程药房为19974例患者提供药学服务，其中新冠肺炎疑似病例6 371例(31.90%)，确诊病例1 213例(6.07%)。对照组药房为9151例患者提供护理，其中新冠肺炎疑似病例1074例(11.74%)，确诊病例33例(0.36%)。在拥有远程药房的药店与没有远程服务的药店相比，远程药房的MDES及其亚类、处方相关错误和药师咨询错误的发生率分别为15.81%比19.43%(p<；0.05)、5.38%比10.08%(p<；0.05)和10.42%比9.35%(p>；0.05)。讨论这是第一批提供高质量证据的研究之一，证明远程药房对新冠肺炎患者获得药物治疗的机会和用药安全性的影响。
IntroductionRemote pharmacist interventions have achieved much more attention during the coronavirus disease 2019 (COVID-19) outbreak, since they reduce the risk of transmission and can potentially increase the access of vulnerable populations, such as patients with COVID-19, to pharmaceutical care. This study aimed to examine differences in rates and types of pharmacist interventions related to COVID-19 and medication dispensing errors (MDEs) across community pharmacies with and without telepharmacy services.MethodsThis was a prospective, disguised, observational study conducted over four months (from March 2020 to July 2020) in 52 community pharmacies (26 with and 26 without telepharmacy) across all seven states of the United Arab Emirates using proportionate random sampling. A standardised data-collection form was developed to include information about patient status, pharmacist interventions and MDEs.ResultsThe test (telepharmacy) group pharmacies provided pharmaceutical care to 19,974 patients, of whom 6371 (31.90%) and 1213 (6.07%) were probable and confirmed cases of COVID-19, respectively. The control group pharmacies provided care to 9151 patients, of whom 1074 (11.74%) and 33 (0.36%) were probable and confirmed cases of COVID-19, respectively. Rates of MDEs and their subcategories, prescription-related errors and pharmacist counselling errors across pharmacies with telepharmacy versus those without remote services were 15.81% versus 19.43% (p < 0.05), 5.38% versus 10.08% (p < 0.05) and 10.42% versus 9.35% (p > 0.05), respectively.DiscussionThis is one of the first studies to provide high-quality evidence of the impact of telepharmacy on COVID-19 patients' access to pharmaceutical care and on medication dispensing safety.